Skip to main content
search

Who are KOLs?

KOLs are key opinion leaders. They are experts in their scientific or therapeutic areas. Their contributions inform the decisions and strategies of healthcare providers, hospitals, pharmaceutical businesses, and medical device providers.

KOL identification and mapping

At Excelra, we identify KOLs relevant to your scientific domain, market, or geography.

The KOL data we provide covers:

  • Physicians
  • Surgeons
  • Caregivers
  • Researchers
  • Investigators
  • Organizations
  • Clinics
  • Clinical trial centers
  • Research institutions

We provide network mapping to identify connections between each data point so you can be extra confident of the quality and relevance of the data provided.

Scoring KOL profiles

Excelra provides scoring for KOL profiles based on a wide set of parameters. We review academic career, professional background, geography, domain specialties, delivered conference presentations, number of publications in peer-reviewed journals, and completed clinical trials.

Once we have collected this information, we apply artificial intelligence algorithms and mathematical models to generate an eminence score for each KOL profile.

KOL data helps healthcare and pharmaceutical companies identify potential challenges and opportunities in the development of new treatments or targeting of particular diseases. Poor KOL data limits the ability to accurately identify challenges and opportunities, so selecting the most eminent, domain-relevant KOLs is of huge importance and can save significant time and money throughout the drug development journey.

Our methodology:

At Excelra, we follow a strict, quality-controlled process to accurately identify, profile, and network-map KOLs.

Each step is completed by our highly qualified and experienced analysts. They identify and profile KOLs who meet the precise requirements set by the client. Then they connect KOLs with organizations and institutions to produce a network map of many inter-connected points.

The data generated from the profiling and network map is then reviewed and verified by subject matter experts to remove any observed inconsistencies and outliers.

To ensure exceptional quality, data is randomly extracted for further review by a quality analyst (QA) or quality control (QC) expert. If our high standards are met, the data is delivered to the client.

We provide the data in any form the client requires, and we offer data integration services to streamline and optimize the client’s ongoing processes.

The benefits of high-quality KOL profile data

  • Helping pharmaceutical companies make confident, well-informed decisions before taking new products to market.
  • Helping patient communities when selecting appropriate pharmaceutical products and treatment modalities.
  • Guiding healthcare professionals to understand patient requirements and driving organizations to meet those requirements.
  • Improving coordination among stakeholders across the healthcare sector.

In pharmaceutical companies and biotechs, KOL data helps take new products (drugs and therapeutic modalities) to patient communities, reduce waiting times for suitable drugs, and improve the efficacy of marketing activities.

In clinical trials, KOL data helps identify appropriate sites for trials and groups of patients. It also helps mitigate challenges associated with trial participation.

In medical device companies, KOL data aids in identifying and connecting target patients, physicians, and hospitals.

Why Excelra?

We’re committed to contributing to discoveries and developments that improve patients’ quality of life.

Our promise:

  • We maintain trusted partnerships
  • We never outsource – all of our data curation is completed manually by our SMEs
  • We provide high-quality disease- and geography-specific KOL profiles
  • We profile and rank KOLs by screening a wide variety of digital sources
  • We provide KOL data that is accurate, non-redundant, and up-to-date